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Abstract
Aflatoxin B1 (AFB1), a food contaminant derived from Aspergillus fungi, has been reported to cause hepatic immunotoxic-
ity via inflammatory infiltration and cytokines release. As a pro-inflammatory factor, cyclooxygenase-2 (COX-2) is widely 
involved in liver inflammation induced by xenobiotics. However, the mechanism by which AFB1-induced COX-2 regulates 
liver inflammatory injury via hepatocytes-Kupffer cells (KCs) crosstalk remains unclear and requires further elucidation. 
Here, we established a COX-2 upregulated model with AFB1 treatment in vivo (C57BL/6 mice, 1 mg/kg body weight, i.g, 
4 weeks) and in vitro (human liver HepaRG cells, 1 μM for 24 h). In vivo, AFB1-treated mice exhibited NLRP3 inflamma-
some activation, inflammatory infiltration, and increased recruitment of KCs. In vitro, dephosphorylated COX-2 by protein 
phosphatase 2A (PP2A)-B55δ promoted NLRP3 inflammasome activation, including mitochondrial translocation of NLRP3, 
caspase 1 cleavage, and IL-1β release. Moreover, phosphorylated COX-2 at serine 601 (p-COX-2Ser601) underwent endo-
plasmic reticulum (ER) retention for proteasome degradation. Furthermore, pyroptosis and inflammatory response induced 
by AFB1 were relieved with COX-2 genetic (siPTGS2) intervention or pharmaceutic (celecoxib, 30 mg/kg body weight, 
i.g, 4 weeks) inhibition of COX-2 via NLRP3 inflammasome suppression in vivo and in vitro. Ex vivo, in a co-culture sys-
tem with murine primary hepatocytes and KCs, activated KCs induced by damaged signals from pyroptotic hepatocytes, 
formed a feedback loop to amplify NLRP3-dependent pyroptosis of hepatocytes via pro-inflammatory signaling, leading 
to liver inflammatory injury. Taken together, our data suggest a novel mechanism that protein quality control of COX-2 
determines the intracellular distribution and activation of NLRP3 inflammasome, which promotes liver inflammatory injury 
via hepatocytes-KCs crosstalk.
Keywords Aflatoxin B1 · Cyclooxygenase-2 · NLRP3 inflammasome · Protein phosphatase 2A · Kupffer cells · Liver 
inflammatory injury
Introduction
Chronic liver inflammation drives hepatic fibrosis and cir-
rhosis, which accounts for more than 1 million deaths per 
year worldwide (Mokdad et al. 2014). Liver inflammatory 
injury is closely related to xenobiotics exposure, which was 
involved in multiple liver diseases, including viral hepati-
tis, alcoholic liver disease (ALD), and nonalcoholic steato-
hepatitis (NASH) (Koyama and Brenner 2017). Aflatoxin 
B1 (AFB1), a carcinogenic mycotoxin widely found in 
mildewed cereals, targets liver tissue through gastrointes-
tinal route (Rushing and Selim 2019). Studies have shown 
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that hepatic regional microenvironment, regulated by pro-
inflammatory cytokines induced by AFB1, promoted liver 
inflammatory injury. The secretion of IL-1β in rat serum was 
increased by AFB1, accompanied by hepatic hemorrhage 
and inflammatory infiltration (Akinrinmade et al. 2016). The 
expression of cyclooxygenase-2 (COX-2) and interleukin-6 
(IL-6) were upregulated via activating nuclear factor-κB 
(NF-κB) signaling pathway in liver tissue of zebrafish with 
AFB1 treatment (Lu et al. 2013). Hepatic cytochrome P450 
(CYP450) was required during the metabolic process from 
AFB1 to its toxic metabolite 8,9-epoxide (AFBO), indicat-
ing hepatocyte damage was the main reason for the hepa-
totoxicity of AFB1 (Ueng et al. 1995). However, due to the 
characteristic of the sinusoidal structure of hepatic regional 
immunity, liver inflammatory injury depends on the com-
position and activity of hepatic immune cells and the cross-
talk with hepatocytes (Byun and Yi 2017). It is necessary to 
further determine the potential mechanism of the crosstalk 
between hepatocytes and hepatic immune cells during AFB1 
exposure.
Pyroptosis, a mode of programmed cell death marked 
by a ruptured plasma membrane, is recently thought to be 
an immunogenic process via releasing damage-associated 
molecular patterns (DAMPs) (Garg et al. 2015; Zhang et al. 
2018). Of the defined inflammasomes, NOD-like recep-
tor protein 3 (NLRP3) inflammasome is well studied in 
response to endogenous or exogenous dangerous signals. 
NLRP3 inflammasome is a multi-protein complex with the 
adaptor, apoptosis-associated speck-like protein containing 
a caspase recruitment domain (ASC) (Lamkanfi and Dixit 
2014). NLRP3 inflammasome functions as a molecular 
platform for the activation of cysteine protease caspase 1, 
leading to maturation and secretion of pro-interleukin-1β 
(pro-IL-1β) and pro-interleukin-18 (pro-IL-18). Meanwhile, 
active caspase 1 cleaves gasdermin D (GSDMD) to form 
pores on cellular plasma membrane (Sarhan et al. 2018). 
Previous studies used to focus on the functional analysis of 
NLRP3 inflammasome in liver resident Kupffer cells (KCs) 
which account for 80–90% of tissue macrophages of the 
whole body (Li et al. 2017; Mridha et al. 2017). However, 
whether NLRP3 inflammasome-related pyroptosis mediates 
hepatocytes-KCs crosstalk remains to be elucidated.
COX-2, a rate-limiting enzyme catalyzing arachidonic 
acid to prostaglandins (PGs), is an endoplasmic reticulum 
(ER)-resident protein widely involved in regional inflam-
matory responses induced by xenobiotics or pro-inflamma-
tory cytokines (Alexanian and Sorokin 2017). Inhibition of 
COX-2 by pharmaceutic (SC-791) or genetic knockdown 
reduced lipopolysaccharide (LPS)-induced NLRP3 inflam-
masome activation of murine macrophage J774A.1 cells by 
decreasing synthesis of PGs and lessening mitochondrial 
oxidative damage (Hua et al. 2015). Although studies have 
demonstrated the correlation between COX-2 and NLRP3 
inflammasome, the mechanism of NLRP3 inflammasome 
activation regulated by COX-2 in liver inflammatory injury 
remains to be elucidated. Interestingly, COX-2 contains a 
phosphorylated motif which can be activated by protein 
tyrosine phosphatase (PTP) in cerebral endothelial cells 
(Alexanian and Sorokin 2017). Therefore, the mechanism 
of the phosphorylation status of COX-2 on its intracellular 
distribution and function has attracted our attention. Protein 
phosphatase 2A (PP2A), a serine/threonine phosphatase, 
is related to cell signaling and hepatotoxicity induced by 
xenobiotics. Because of the diversity of B subunits in the 
holoenzyme trimer, PP2A has substrate-specificity and tar-
geted-selectivity (Reynhout and Janssens 2018). Whether 
NLRP3 inflammasome activation is regulated by dephos-
phorylation of COX-2 modified by PP2A remains to be stud-
ied. In the present study, we establish a COX-2 upregulated 
model with AFB1 in vivo and in vitro. We for the first time 
reveal that protein quality control (PQC) of COX-2, PP2A-
B55δ-mediated dephosphorylation of COX-2Ser601 induced 
by AFB1, altered ER localization of COX-2 and promoted 
recruitment and activation of NLRP3 inflammasome in 
hepatocytes. Moreover, a positive feedback loop from acti-
vated KCs to hepatocytes stimulated immune cascade and 
amplified liver inflammatory injury.
Materials and methods
Gene expression omnibus (GEO) database analysis
The mRNA expression dataset GSE25844 was obtained 
from the GEO database (http://www.ncbi.nlm.nih.gov/
geo/). Three independent biological replicates of HepaRG 
cells were stimulated with AFB1 (0.05, 0.25 μM) for 24 h. 
The relative expression of indicated genes in AFB1-treated 
group was compared with the control group. And the cor-
relations between relative expression of indicated genes were 
analyzed by Pearson’s correlation regression analysis.
In vivo experimentation
C57BL/6 mice (15–25 g) were randomly divided into groups 
as follows: control (corn oil), celecoxib (CELE, MedChem-
Express, NJ, USA) treated (30 mg/kg, i.g, CELE group), 
AFB1 (Fermentek, Israel) treated (1  mg/kg, i.g, AFB1 
group), and AFB1 with combined treatment of CELE 
(AFB1 + CELE group) (n = 12 in each group). CELE or 
AFB1 was dissolved in corn oil in a volume less than 200 
μL. The mice were intragastrically administered every other 
day for 4 weeks. All mice were sacrificed for experimental 
purposes after 24 h from the last exposure. Animal Ethical 
Committee of Xiamen University approved all the animal 
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experiments which were conducted in accordance with the 
guidelines of the National Institutes of Health (NIH).
Ex vivo experimentation
Primary hepatocytes The previously described improved 
method of “the in situ two-step collagenase perfusion to 
heart-based perfusion” was followed (Li et al. 2010). In 
brief, after 8 h fasting, mice were anesthetized and fixed on 
the anatomical board. Apex cordis and liver were exposed 
to insert needle at ventriculus sinister. The perfusion was 
conducted sequentially with calcium-free solution (NaCl 
8.3 g/L, KCl 0.5 g/L, HEPES 2.4 g/L, EGTA 0.38 g/L, pH 
7.4) and collagenase solution (NaCl 3.9 g/L, KCl 0.5 g/L, 
HEPES 2.4 g/L,  CaCl2 0.55 g/L, pH 7.6) containing col-
lagenase IV (Solabio, Beijing, China) until liver couldn’t 
rebound after pressing. The perfusion solutions were pre-
heated at 37 °C and the flow rate was 60 r/min. Liver was 
completely detached from the digestion with collagenase IV, 
DNases (Solabio) and proteinase K (Merck, Germany), for 
5–10 min at 37 °C. The liver capsule was torn off to obtain 
cell suspension and centrifuged at 50×g for 3 min for 3 times 
after passing through a 200-mesh filter. About 5 × 105 cells 
per well were seeded into a 6-well plate after counting, and 
the medium was replaced after cell adherence about 4 h.
Primary KCs Liver was extracted by anatomical separa-
tion after execution, and digested by mouse Liver Dissocia-
tion Kit (Miltenyi Biotec, Germany) using gentleMACS™ 
Dissociators (Miltenyi Biotec) to obtain cell suspension. 
KCs were sorted by MACS magnetic microbeads coated 
with anti-F4/80 antibody and MACS columns (Miltenyi Bio-
tec), according to KCs’ surface marker expression. About 
2.5 × 105 KCs per well were seeded into the lower or upper 
chamber of transwell (Corning, NY, USA) for co-culture 
with primary hepatocytes after elution, and the medium was 
replaced after cell adherence about 2 h.
Primary cells were cultured in Williams’ Medium E 
with GlutaMAX-I (Gibco, CA, USA) supplemented with 
10% fetal bovine serum (FBS) (Gibco), 1% (v/v) penicillin-
streptomycin (Life, NY, USA), 4 μg/mL of bovine insulin 
(Wanbang, Jiangsu, China), and 5 × 10-5 mol/L of hydrocor-
tisone hemisuccinate (Sigma, MO, USA).
In vitro experimentation
HepaRG cells were obtained from the National Institute of 
Diagnostics and Vaccine Development in Infectious Dis-
eases (Xiamen University). Cell culture and differentiation 
for HepaRG cells were described in our previous study (He 
et al. 2018). Human normal hepatic cell line L02 and human 
embryonic kidney cell line HEK-293T were maintained in 
our laboratory, cultured in RPMI 1640 medium (Hyclone, 
UT, USA) and in Dulbecco’s Modified Eagle Medium 
(DMEM) high glucose medium (Hyclone) which was sup-
plemented with 10% FBS and 1% (v/v) penicillin-strepto-
mycin, respectively. All cells were maintained at 37 °C in a 
humidified atmosphere of 5%  CO2.
Site‑directed mutagenesis
High-fidelity KOD-Plus enzyme was performed by inverse 
PCR with KOD-Plus Mutagenesis Kit (Toyobo, Japan). As 
a DNA template, pB-PTGS2-Flag was completely amplified 
with two primers in the opposite direction, to generate base 
mutation from serine to alanine (S to A) or to aspartate (S 
to D) at serine 582, 583, 584, 586, and 601 of COX-2. Then, 
the PCR products were self-ligated by T4 polynucleotide 
kinase. The primers were listed in Table S1 and indicated 
bases of mutant sites were underlined and bolded. Construc-
tion of pB-PTGS2 and establishment of stable cell lines were 
as described in our previous study (Liao et al. 2015).
Statistics
Data were expressed as mean ± standard deviation (SD) of 
at least three independent experiments. Statistical analyses 
were executed with Statistical Package for Social Sciences 
(SPSS) version 16.0. Unpaired Student’s t-test and one-way 
analysis of variance (ANOVA) were applied for determin-
ing the statistical significance. P < 0.05 was considered as 
significant difference.
Results
GEO analysis of pro‑inflammatory genes induced 
by AFB1 in HepaRG cells
In this study, the outcomes of regulatory cell death (RCD) 
were concerned in hepatocytes induced by AFB1. It is 
known that members of the caspase family are the most 
important molecules in various RCD (Julien and Wells 2017; 
Van Opdenbosch and Lamkanfi 2019). To investigate AFB1-
induced liver inflammatory injury and cell death patterns of 
hepatocytes, the levels of caspase-related genes in AFB1-
treated HepaRG cells were analyzed using the GEO dataset 
(GSE25844). Among caspase-related genes, the relative 
levels of CASP1 (encoding gene for caspase 1) and CASP3 
(encoding gene for caspase 3) increased significantly in 
AFB1-treated HepaRG cells (Fig. 1a). Caspase 1-dependent 
pyroptosis and caspase 3-dependent apoptosis were regarded 
as immunogenic cell death, which suggest AFB1 induced 
liver inflammatory injury via releasing DAMPs from dying 
hepatocytes. Moreover, the relative level of PTGS2 (encod-
ing gene for COX-2), a pro-inflammatory gene, was upregu-
lated in AFB1-treated HepaRG cells (Fig. 1b). The relative 
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level of PTGS2 was positively correlated with CASP1 
(r = 0.5913, P < 0.05) or IL1B (encoding gene for IL-1β) 
(r = 0.7564, P < 0.05), while the correlation of PTGS2 with 
CASP3 was not significant (Fig. 1c). As mentioned before, 
active caspase 1 determines the rupture of cellular plasma 
membrane and maturation of IL-1β. These results indicate 
that liver inflammatory injury induced by AFB1 was closely 
related to caspase 1-dependent pyroptosis and the expression 
of COX-2.
Inhibition of COX‑2 reversed liver inflammatory 
injury induced by AFB1 in vivo
Interestingly, consistent with the outcomes observed from 
GEO analysis, the protein levels of COX-2, p10 (the active 
form of caspase 1), and IL-1β were upregulated in liver 
tissues of AFB1-exposed mice in our study (Fig. S1a). 
To further verify the role of COX-2 in liver inflammatory 
injury and its relationship with pyroptosis of hepatocytes, 
we established an exposure model of AFB1 and a CELE 
intervention model (a selective inhibitor of COX-2) in vivo. 
The growth curve of AFB1- or CELE-treated group had 
no significant changes compared to the control group (Fig. 
S1b). In AFB1-exposed mice, the mRNA levels of hepatic 
Cyp1a2 and Cyp3a11 of CYP450 were upregulated, while 
Gsta, Gstm, and Gstt of glutathione S-transferase (GSTs) 
were downregulated (Fig. S1c), indicating the metabolic 
activation in AFB1-treated group. Moreover, the mRNA 
level of Ptgs2 was increased in AFB1-treated group, and 
decreased in CELE-treated group (Fig. S1c), indicating that 
the induction of COX-2 in liver tissue could be upregulated 
by AFB1 and as a target for intervention with CELE. In 
AFB1-exposed mice, the ratio of liver/body weight was 
increased (Fig. 2a). Moreover, inflammatory foci, inflam-
matory infiltration of KCs, cell death, and slight collagen 
deposition were observed in AFB1-treated group (Fig. 2a), 
consistent with the enhanced hepatic mRNA level of pro-
inflammatory cytokines, Il1b, Il18, Il6, and Tnfa (Fig. 2b), 
indicating that AFB1 promoted a pro-inflammatory micro-
environment in liver. And the activities of ALT and AST in 
liver homogenization were increased (Fig. 2c), but remained 
unchanged in serum (Fig. S1d), prompting that pro-inflam-
matory environment induced by AFB1 contributed to liver 
inflammation and injury. However, the mRNA level of pro-
inflammatory cytokines, inflammatory infiltration, and liver 
injury were reduced in CELE pre-treated AFB1-exposed 
Fig. 1  GEO analysis of pro-inflammatory genes in HepaRG cells 
induced by AFB1. a–c The relative mRNA levels of indicated genes 
were obtained from NCBI, GEO database (GSE25844). HepaRG 
cells were stimulated with AFB1 (0.05, 0.25 μM) for 24 h. The heat-
map of the relative mRNA levels of caspase family (a), the relative 
mRNA level of PTGS2 (b), and the linear correlation between the rel-
ative mRNA levels of PTGS2 and CASP3, CASP1, or IL1B (c) were 
represented. *P < 0.05, compared with control group
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mice, indicating that targeted intervention of COX-2 selec-
tively inhibited the pro-inflammatory environment and 
liver inflammatory injury induced by AFB1. Furthermore, 
the levels of proteins representing assembly (NLRP3, ASC, 
and p10) and activation (IL-1β and GSDMD) of NLRP3 
inflammasome in liver tissues were enhanced in AFB1-
exposed mice (Fig. 2d). Moreover, the assembly and activa-
tion of NLRP3 inflammasome were reduced in CELE group, 
indicating that CELE intervention was useful for the inhibi-
tion of liver inflammation. Furthermore, in AFB1-exposed 
Fig. 2  Inhibition of COX-2 reversed liver inflammatory injury 
induced by AFB1 in  vivo. C57BL/6 mice were treated with AFB1 
(1 mg/kg, i.g, AFB1 group) or/and celecoxib (30 mg/kg, i.g, CELE 
group) for 4 weeks. n = 12 in each group. a Inflammatory foci (black 
arrow) and cell death (black triangle), collagen deposition (green tri-
angle), inflammatory infiltration of KCs (green arrow) were detected 
by hematoxylin and eosin (HE) staining, Sirius red staining and 
IHC analysis of anti-F4/80 antibody (left panel). Scale bar 50 μm or 
100  μm. Quantification of inflammatory foci was shown in the bar 
chart (right panel). Liver/body weight ratio was shown in the bar 
graph. b Hepatic mRNA expression of pro-inflammatory cytokines, 
Il-1b, Il-18, Il-6, and Tnf-a, was detected by qRT-PCR. c Activi-
ties of ALT (left) and AST (right) in liver homogenate indicated 
liver injury were measured. d The expression of COX-2 and NLRP3 
inflammasome-related proteins was examined by western blot (WB). 
e Serial sections were used for IHC analysis for the expression of 
COX-2 and caspase 1. f IL-1β level of liver homogenate was quan-
tified by enzyme-linked immunosorbent assay (ELISA). GAPDH or 
ACTB was served as a loading control for WB and qRT-PCR analy-
sis. Representative examples were displayed. All data were shown 
as mean ± SD (n = 3). *P < 0.05, compared with control group. 
#P < 0.05, compared with AFB1 treated group (colour figure online)
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mice, the expressions of COX-2 and caspase 1 at the same 
location were upregulated, determined using immunohisto-
chemical (IHC) analysis (Fig. 2e). A decreased expression 
of caspase 1 was observed, consistent with reduced COX-2 
in CELE-treated group. In addition, IL-1β secretion in serum 
and liver homogenate was increased in AFB1-treated group, 
but reduced in CELE-treated group (Fig. S1e; Fig. 2f), indi-
cating that AFB1 induced liver regional inflammation via 
NLRP3 inflammasome activation and the process mediated 
by the induced COX-2. In short, these results suggest that 
AFB1 induced NLRP3-dependent pyroptosis of hepatic cells 
via upregulated COX-2. DAMPs and IL-1β released from 
the pyroptotic hepatocytes promoted a series of pro-inflam-
matory responses to form a hepatic regional immune micro-
environment and induce liver inflammation. The selective 
inhibition of COX-2 could alleviate pyroptotic cell death, 
pro-inflammatory response, and liver inflammatory injury.
Kupffer cells enhanced NLRP3 inflammasome 
activation of hepatocytes through inflammatory 
signaling
To investigate whether the hepatic immune microenviron-
ment was mediated by NLRP3 inflammasome-dependent 
pyroptosis and was via the crosstalk between hepatocytes 
and hepatic regional immune cells, the specific subsets of 
immune cells were analyzed by flow cytometry ex vivo. 
The ratio of hepatic monocytes, marked by CD11c, had no 
significant changes in AFB1-treated group (Fig. S1f). The 
subset of hepatic resident macrophage, namely KCs marked 
by F4/80, is a source of pro-inflammatory cytokines. It was 
found that the proportion of F4/80-positive KCs in liver 
non-parenchymal cells was augmented in AFB1-treated 
group (16.57%), and was inhibited in CELE-treated group 
(5.71%) (Fig. 3a). These results indicate that KCs might play 
an important role in activating immune cascades of hepatic 
local immunity to aggravate liver regional inflammation.
To further explore the mechanism of activated KCs-
mediated regional immune cascades for liver inflammatory 
injury, primary KCs and hepatocytes were obtained to estab-
lish a co-culture model ex vivo. In primary KCs, the nuclear 
translocation of NF-κB (p65), activator protein-1 (AP-1), 
and c-JUN were increased, accompanied with the enhanced 
expression of signal transducer and activator of transcrip-
tion 3 (STAT3) in AFB1-treat group (Fig. 3b). This indi-
cated that KCs were activated via nuclear transcriptional-
dependent pro-inflammatory signaling. Except for enhanced 
expression of NLRP3 and pro-IL-1β regulated by NF-κB in 
primary KCs in AFB1-treat group (Fig. 3b), the levels of 
COX-2, and proteins representing assembly (NLRP3, ASC, 
and p10) and activation (IL-1β and GSDMD) of NLRP3 
inflammasome were upregulated in primary hepatocytes 
(Fig. 3c). Moreover, IL-1β secretion in the supernatant of 
both primary hepatocytes and KCs were increased in AFB1-
treated group and decreased after COX-2 intervention in 
CELE-treated group (Fig. 3d). These results indicate that 
AFB1 induced NLRP3 inflammasome-dependent pyropto-
sis via upregulated COX-2 in both hepatocytes and KCs. 
Furthermore, in a co-culture system of primary hepatocytes 
and KCs from the control group, with the administration 
of AFB1 after cell adherence, the protein levels of COX-2, 
NLRP3, ASC, p10, IL-1β, and GSDMD in primary hepato-
cytes were upregulated, consistent with the increased IL-1β 
secretion in the supernatant (Fig. 3e). And in the co-culture 
system of primary hepatocytes and KCs from AFB1-treated 
group, primary hepatocytes were treated with CY-09 after 
adherence, an inhibitor of NLRP3 synthesized previously 
(Jiang et al. 2017). The protein levels described above in 
primary hepatocytes were downregulated, consistent with 
the reduced IL-1β secretion in the supernatant (Fig. S1g).
To elucidate the crosstalk between KCs and hepatocytes 
in liver inflammatory injury, primary hepatocytes and KCs 
were obtained from un-treated C57BL/6 mice and re-seeded 
into monolayer or transwell chamber for co-culture, with 
additional AFB1 treatment after cell adherence. Compared 
to hepatocytes of monolayer-culture, the protein levels of 
COX-2, NLRP3, ASC, p10, IL-1β, and GSDMD were sig-
nificantly upregulated in hepatocytes of co-culture with KCs 
(Fig. 3f), indicating that KCs formed a feedback loop to 
hepatocytes via aggravating NLRP3 inflammasome activa-
tion. In general, AFB1 induced NLRP3-dependent pyrop-
tosis of hepatocytes to augment pro-inflammatory signaling 
of KCs and the activated KCs aggravated NLRP3 inflamma-
some activation of hepatocytes, which formed a vice cycle 
to enhance liver inflammatory injury.
AFB1 induced NLRP3 inflammasome activation 
and plasma membrane rupture in HepaRG cells
With the GEO dataset (GSE87028), analysis for other mem-
bers of the NLR family were performed. The relative expres-
sion levels of NLR family members in HepaRG cells with 
AFB1 treatment were shown in figures S2a and S2b. Indeed, 
the relative levels of NLRP1 and NLRP3 were significantly 
upregulated (Fig. S2a). Furthermore, the relative levels of 
PTGS2 and NLRP3 were positively correlated in AFB1-
treated HepaRG cells (Fig. S2b). With our experiments, the 
transcription of NLR families’ genes (including NLRP1, 
NLRP2, NLRP3, and NLRC4) was examined in HepaRG 
cells exposed to AFB1, while the mRNA level of NLRP3 
gene was significantly increased (Fig. S2c).
To further verify the mechanism of pyroptosis induced by 
AFB1 in vitro, the differentiated HepaRG cells were treated 
with 1 μM AFB1 for 24 h. And the metabolic activity of 
differentiated cells was verified by the expression of hepatic 
CYP1A1, 2B6, 3A4, and 7A1 (Fig. S2d). The features of 
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pyroptosis, including pyroptosis bodies of early phase and 
membrane rupture of terminal phase, were observed using 
transmission electron microscope (TEM) (Fig. 4a). With 
immunofluorescence (IF) analysis, cytoplasmic expansion 
and increased fluorescent signal of GSDMD were observed 
(Fig.  4b). These data indicate pyroptosis was induced 
in HepaRG cells with AFB1 treatment. Then, we fur-
ther studied whether pyroptosis of hepatocytes is NLRP3 
Fig. 3  Kupffer cells enhanced NLRP3 inflammasome activation of 
hepatocytes through inflammatory signaling. Primary hepatocytes 
and KCs were obtained by heart-liver perfusion and magnetic beads, 
respectively. a The proportion of F4/80-positive cells (indicated KCs) 
of hepatic non-parenchymal cells was detected by flow cytometry 
analysis after digestion of the liver (left panel). Quantification of flu-
orescence intensity was shown in the bar chart (right panel). b The 
protein levels of NF-κB (p65), AP-1, c-JUN, and STAT3 in cytosolic 
(Cyto) or nuclear (Nucleus) fraction of primary KCs were detected by 
WB. c The expression of COX-2 and NLRP3 inflammasome-related 
protein of primary hepatocytes were examined by WB. d IL-1β secre-
tion in the supernatants from primary KCs (upper panel) and hepato-
cytes (lower panel) were quantified by ELISA. e Primary hepatocytes 
and KCs from corn oil-treated control group were obtained and re-
seeded in the lower and upper chamber of transwell for 48 h, respec-
tively. And primary hepatocytes were treated with AFB1 (1  μM, 
24  h). Proteins representing NLRP3 inflammasome activation and 
COX-2 were detected by WB, and IL-1β secretion in the supernatant 
was quantified by ELISA. f Primary hepatocytes were obtained from 
non-treated C57BL/6 mice, and re-seeded into monolayer or lower 
chamber of the transwell. For co-culture, primary KCs from non-
treated C57BL/6 mice were re-seeded into the upper chamber of the 
transwell. Indicated protein levels of primary hepatocytes from mon-
olayer- or transwell-culture were detected by WB. GAPDH served 
as a loading control for WB analysis. Representative examples were 
displayed. All data were shown as mean ± SD (n = 3). *P < 0.05, com-
pared with control group. #P < 0.05, compared with AFB1 treated 
group
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inflammasome dependent. Nuclear translocation of NF-κB 
(p65), expression of NLRP3, and pro-IL-1β were enhanced 
(Fig. 4c). Meanwhile, increased mitochondrial transloca-
tion of NLRP3 and its co-localization with ASC suggest 
that the recruitment and assembly activation of NLRP3 
were dependent on mitochondria and essential for caspase 
1 activity (Fig. 4d; Fig. S2e, S2f). The proteins representing 
downstream of caspase 1 activation, including p10, IL-1β, 
and GSDMD were also upregulated (Fig.  4e). Consist-
ent with observed membrane rupture, lactate dehydroge-
nase (LDH) leakage and IL-1β release were significantly 
increased (Fig. 4f, g), which could be relieved by CY-09. 
However, changes in TNF-α release in the supernatant were 
not observed (Fig. 4h). In brief, these results indicate that the 
NLRP3 inflammasome activation and the membrane rupture 
induced by AFB1 lead to pyroptosis of hepatocytes.
NLRP3 inflammasome activation was regulated 
via AFB1‑induced COX‑2 upregulation
Consistent with the upregulation of COX-2 induced by 
AFB1 in liver tissue or primary hepatocytes in vivo or 
ex vivo model, the level of PTGS2 mRNA and COX-2 pro-
tein were upregulated in AFB1-treated HepaRG cells (Fig. 
Fig. 4  AFB1 induced NLRP3 inflammasome activation and plasma 
membrane rupture in HepaRG cells. Differentiated HepaRG cells 
were treated with AFB1 (1  μM, 24  h). a Pyroptosis bodies (black 
arrows) and membrane rupture (white arrows) were observed by a 
transmission electron microscope. E early phase, T terminal phase, 
N nucleus, M mitochondrion. Scale bar 2 μm or 1 μm. b Cells were 
subjected to IF staining of anti-GSDMD (green) and detected by con-
focal microscopy. ER-Tracker staining (red) represented the ER, and 
DAPI staining (blue) represented the nucleus. Scale bar 10 μm. c The 
protein levels of NF-κB (p65), NLRP3, and pro-IL-1β from cytoplas-
mic (Cyto) or nuclear (Nucleus) fractions were determined by WB. 
d The protein levels of NLRP3 and COX-2 from cytoplasmic (Cyto) 
or mitochondrial (Mito) fractions were detected by WB. (e) Proteins 
representing the assembly (NLRP3, ASC, and p10) and activation 
(IL-1β and GSDMD) of NLRP3 inflammasome were determined by 
WB, treated with the indicated concentration of AFB1 for 24 h. f–h 
Cells were co-treated with CY-09 (1  μM, 24  h) and AFB1 (1  μM, 
24 h) or not. Plasma membrane rupture was analyzed by LDH release 
assay (f). IL-1β and TNF-α secretion in the supernatants was quanti-
fied by ELISA (g, h). GAPDH, Histone 3, and COXIV were served as 
the loading control of Cyto, Nucleus, and Mito fractions, respectively. 
Representative examples were displayed. All data were shown as 
mean ± SD. *P < 0.05, compared with control group. #P < 0.05, com-
pared with AFB1 treated group (colour figure online)
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S2g). Moreover, mitochondrial translocation of COX-2 
was observed as that of NLRP3, which indicate that 
COX-2 was localized closely with NLRP3 on mitochon-
dria (Fig. 4d). To further investigate the role of COX-2 in 
the activation of the NLRP3 inflammasome, we used small 
interfering RNA (siRNA) for PTGS2 (siPTGS2) to sup-
press the expression of COX-2. Compared to AFB1-treated 
siRNA negative control (siNC) cells, the fluorescence 
intensity of COX-2 and co-localization between NLRP3 
and MitoTracker were decreased in AFB1-treated siPTGS2 
cells, indicating that COX-2 intervention reduced the mito-
chondria translocation of NLRP3 (Fig. 5a). Proteins rep-
resenting assembly (NLRP3, ASC, and p10) and activa-
tion (IL-1β and GSDMD) of NLRP3 inflammasome were 
reduced after COX-2 intervention (Fig. 5b), accompanied 
by the decreased LDH leakage and IL-1β release (Fig. 5c, 
d). These results suggest that COX-2 regulated the mito-
chondrial recruitment and activation of the NLRP3 inflam-
masome, which might contribute to pyroptosis for DAMPs 
and IL-1β release.
Dephosphorylation of COX‑2 by PP2A‑B55δ 
regulated NLRP3 inflammasome activation
It has been demonstrated that COX-2 contained a phospho-
rylated motif, which was crucial for its activity and function 
(Alexanian and Sorokin 2017). To investigate the contri-
bution of the phosphorylated status of COX-2 on NLRP3 
inflammasome activation, we established a series of cell 
lines expressing phosphorylation (aspartate mutation from 
serine) or dephosphorylation (alanine mutation from serine) 
of COX-2. As predicted with the PhosphoNET and DIS-
PHOS previously, serine 582, 583, 584, 586, and 601 were 
the possible phosphorylated sites at C-terminus of COX-2 
(Fig. S3a, S3b). These five serine (S) sites were mutant 
to alanine (A) or aspartate (D) respectively, representing 
dephosphorylated or phosphorylated COX-2, as shown in 
the schematic view (Fig. 6a). Compared with L02-pBabe 
cells (wild type control), the increased expression of NLRP3 
and ASC were observed in COX-2S601A cells (with dephos-
phorylated COX-2), consistent with upregulated IL-1β and 
GSDMD through caspase 1 cleavage (Fig. 6b). Moreover, 
Fig. 5  NLRP3 inflammasome activation was regulated via upregu-
lated COX-2 induced by AFB1. Differentiated HepaRG cells were 
transfected with siNC or siPTGS2 (50  nM) for 6  h, followed by 
AFB1 treatment (1  μM 24  h). a The expression of COX-2 (green) 
and NLRP3 (blue), and co-localization of MitoTracker (red) and 
NLRP3 were examined by confocal microscopy (upper panel). Scale 
bar 10 μm. And Pearson’s correlation for the co-localization of mito-
chondria with NLRP3 was shown in the bar graph (lower panel). The 
overlap sections of mitochondria and NLRP3 were quantified using 
ImagePro-plus 6.0. b The levels of COX-2 and NLRP3 inflammas-
ome-related proteins were examined by WB. c Plasma membrane 
rupture was analyzed by LDH release assay. d IL-1β secretion in the 
supernatants was quantified by ELISA. GAPDH served as a loading 
control for WB analysis. Representative examples were displayed. All 
data were shown as mean ± SD. *P < 0.05, compared with siNC con-
trol group. #P < 0.05, compared with siNC and AFB1-treated group 
(colour figure online)
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Fig. 6  Dephosphorylation of COX-2 by PP2A-B55δ regulated 
NLRP3 inflammasome activation. a The schematic view of C-termi-
nal site-specific mutagenesis of COX-2. Serine 582, 583, 584, 586, 
and 601 were mutated to alanine (S to A) for mimicking dephospho-
rylation or aspartate (S to D) for mimicking phosphorylation of COX-
2. b–d In L02-pB cells, L02-PTGS2 cells, or mimic phosphorylated/
dephosphorylated COX-2 cells at indicated sites, the expression of 
NLRP3 inflammasome-related proteins were examined by WB (b). 
Plasma membrane rupture was analyzed by LDH release assay (c), 
and IL-1β secretion in the supernatants was quantified by ELISA (d). 
e After treatment of AFB1 (1 μM, 24 h), cell lysates were immuno-
precipitated with anti-COX-2 antibody, and both IP and total lysates 
(Input) were immunoblotted for COX-2, B55δ, and NLRP3. f–i Dif-
ferentiated HepaRG cells were transfected with siNC or siPPP2R2D 
(50  nM) for 6  h, followed by AFB1 treatment (1  μM 24  h). The 
expression of B55δ, COX-2, and NLRP3 inflammasome-related pro-
tein were examined by WB (f). The expression of B55δ (green) and 
NLRP3 (blue), and co-localization of MitoTracker (red) and NLRP3 
was examined by confocal microscopy (right panel). Scale bar 10 μm. 
Pearson’s correlation for the co-localization of mitochondria with 
NLRP3 was shown in the bar graph (left panel). The overlap sections 
of mitochondria and NLRP3 were quantified using ImagePro-plus 6.0 
(g). Plasma membrane rupture was analyzed by LDH release assay 
(h), and IL-1β secretion in the supernatants was quantified by ELISA 
(i). GAPDH served as a loading control for WB analysis. Representa-
tive examples were displayed. All data were shown as mean ± SD. 
*P < 0.05, compared with L02-pB cell or siNC control group. 
#P < 0.05, compared with L02-PTGS2 cell or siNC  and AFB1-treated 
group (colour figure online)
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compared to COX-2S601A cells, proteins representing 
assembly (NLRP3, ASC, and p10) and activation (IL-1β 
and GSDMD) of NLRP3 inflammasome were decreased in 
COX-2S601D cells (with phosphorylated COX-2) (Fig. 6b). 
However, cells harboring other mutant sites had no signifi-
cant alteration between dephosphorylated and phosphoryl-
ated form of COX-2. These results indicate that the phos-
phorylated status of COX-2Ser601 mediated the function of 
COX-2 for NLRP3 inflammasome activation. Meanwhile, 
LDH leakage and IL-1β release were significantly increased 
in dephosphorylated or phosphorylated COX-2-overex-
pressing cells (Fig. 6c, d). Moreover, the LDH leakage and 
IL-1β release in COX-2S601D cells were significantly reduced 
compared to COX-2S601A cells. These results demonstrate 
that regulatory phosphorylated status of COX-2Ser601 as a 
potential functional site was important for its activity, and 
dephosphorylated regulation of COX-2Ser601 played a role in 
NLRP3 inflammasome activation.
Protein phosphatases (PPs), including the protein phos-
phatase 1 (PP1) and PP2 families in mammals, are known to 
regulate the dephosphorylation of different protein substrates 
(Bertran et al. 2019; Virshup and Shenolikar 2009). PP2A, 
a serine/threonine phosphatase, functions as a complex con-
taining catalytic C, scaffold A, and regulatory B subunit fam-
ily (Alvarez-Fernandez et al. 2018). The substrate targeting 
and specificity of PP2A are determined by its multifarious B 
subunits (Reynhout and Janssens 2018). With the GEO data-
set (GSE25844), the relative expression levels of PPP1CA 
(encoding gene for PP1Cα catalytic subunit in PP1 family) 
and PPP2R2D (encoding gene for B55δ subunit in PP2A 
family) were significantly increased in AFB1-treated Hep-
aRG cells (Fig. S3c, S3d). With our experiments, the mRNA 
levels of PPP1CA, PPP2R2A, and PPP2R2D were increased 
in AFB1-induced pyroptosis model of HepaRG cells (Fig. 
S3e). Furthermore, the positive correlation between the rela-
tive expression level of PPP2R2D and PTGS2, CASP1, or 
GSDMD (r = 0.6680, 0.5591, 0.5908, P < 0.05) was shown 
(Fig. S3f). In AFB1-exposed mice, the expression of B55δ 
was upregulated at the same location with COX-2 on serial 
sections by IHC analysis (Fig. S3g). Moreover, the enhanced 
protein-protein interaction between COX-2 and B55δ after 
AFB1 treatment was detected by immunoprecipitation (IP) 
assay (Fig. 6e), indicating that COX-2 might be dephospho-
rylated by PP2A-B55δ. To further investigate whether the 
phosphorylated status of COX-2 and its downstream func-
tions could be regulated by B55δ, we established a knock-
down model with siPPP2R2D. Compared to AFB1-treated 
siNC cells, the protein levels of B55δ, COX-2, and proteins 
representing assembly (NLRP3, ASC, and p10) and activa-
tion (IL-1β and GSDMD) of NLRP3 inflammasome were 
decreased (Fig. 6f). The fluorescence intensity of B55δ 
and co-localization between NLRP3 and mitochondria was 
inhibited in AFB1-treated siPPP2R2D cells (Fig. 6g), which 
consistent with reduced LDH leakage and IL-1β release with 
B55δ intervention (Fig. 6h, i), indicating that B55δ dephos-
phorylated COX-2 mediated NLRP3 inflammasome activa-
tion and pyroptosis-related plasma membrane rupture. These 
results suggest that dephosphorylated COX-2Ser601, mediated 
by PP2A-B55δ, regulated its function for NLRP3 inflamma-
some activation.
Phosphorylation status of COX‑2Ser601 determined 
its ER localization and degradation
Studies have revealed that N-glycosylated COX-2 at aspar-
agine 594 determined its subcellular localization and 19 
amino acids at C-terminal (Asn594-Lys612) were impor-
tant for its degradation (Mbonye and Song 2009; Yuan and 
Smith 2015). In the present study, compared to COX-2S601A 
cells, co-localization of COX-2 and ER-Tracker was stronger 
in COX-2S601D cells detected by IF assay, indicating that 
phosphorylated COX-2Ser601 tends to remain in ER (Fig. 7a). 
The study has shown that Derlin 1, an ER-associated deg-
radation (ERAD) core protein, could interact with COX-2 
at C-terminal for cytosolic proteasome degradation (Chen 
et al. 2013; Mbonye et al. 2008). Compared to COX-2S601A 
cells, the protein-protein interaction between COX-2 and 
Derlin 1 was increased in COX-2S601D cells as detected by 
IP assay, while the interaction between COX-2 and B55δ 
was decreased (Fig. 7b). Meanwhile, compared to un-treated 
siNC cells, the protein-protein interaction and fluorescent 
co-localization between COX-2 and Derlin 1 were reduced, 
as analyzed by IP and IF assay, respectively (Fig. 7c, d), 
indicating that AFB1 inhibited the ERAD process of COX-2 
via blocking COX-2-Derlin 1 interaction. Furthermore, 
compared to AFB1-treated siNC cells, the COX-2-Derlin 1 
interaction was enhanced with B55δ intervention (Fig. 7c, 
d), indicating that PP2A-B55δ induced by AFB1 regulated 
ERAD of COX-2 via dephosphorylation of COX-2Ser601. 
These data suggest that dephosphorylated modification of 
COX-2Ser601 by PP2A-B55δ determined its ER retention for 
proteasome degradation.
Discussion
We applied a COX-2 upregulation model with AFB1 to 
investigate the role of COX-2 in hepatic microenvironment 
during liver inflammatory progress. An upregulated hepatic 
mRNA level of Ptgs2, increased inflammatory infiltration, 
and an especially increased number of KCs were observed 
in vivo. CELE, a selective inhibitor of COX-2, relieved the 
inflammatory infiltration induced by AFB1, indicating that 
COX-2 may function as a potential molecular target for liver 
inflammatory injury. In the existing studies, COX-2 is pro-
posed to have protective roles in multiple processes such as 
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oxidative stress, liver inflammation, and fibrosis in hepato-
cyte-specific COX-2 transgenic (hCOX-2-Tg) mice; however, 
the pro-inflammatory role of COX-2 remain a focus (Motino 
et al. 2016, 2019). In different models, hepatic metabolic 
enzymes may influence oxidative stress and inflammatory 
mediators (Cobbina and Akhlaghi 2017). In our study with 
AFB1-treated mice model, Cyp1a2 and Cyp3a11 of hepatic 
CYPs, phase I drug-metabolizing enzymes for metabolism 
were upregulated, while Gsta, Gstm, Gstt of GSTs, phase II 
drug-metabolizing enzymes for detoxification were down-
regulated. In the current in vitro studies, we used HepaRG 
cells and primary hepatocytes because they are metaboli-
cally competent to solve the loss of metabolic capacity in 
immortalized cells lines (Bell et al. 2017; Yuan et al. 2018).
Consistent with a report demonstrating that AFB1 formed 
a hepatic pro-inflammatory microenvironment in zebrafish 
via transcriptional activity of NF-κB, promoting expres-
sion of COX-2 and IL-6 (Lu et al. 2013), our study showed 
that hepatic mRNA level of pro-inflammatory cytokines, 
Ptgs2, Il1b, Il18, Il6, and Tnfa were significantly increased 
after AFB1 treatment. Due to the ability of KCs for secret-
ing various cytokines, we supposed a KCs-hepatocytes 
Fig. 7  Phosphorylation status of COX-2Ser601 determined its ER 
localization and degradation. a After treatment of AFB1 (1  μM, 
24  h), the expression of COX-2 (green) in COX-2S601A and COX-
2S601D cells was examined by confocal microscopy (left panel) ER-
Tracker staining (red) represented the ER, and DAPI staining (blue) 
represented the nucleus. Scale bar 10  μm. Pearson’s correlation for 
the co-localization of ER and COX-2 was shown in the bar graph 
(right panel). The overlap sections of ER and COX-2 were quantified 
using ImagePro-plus 6.0. b Cell lysates of COX-2S601A and COX-
2S601D were immunoprecipitated with anti-Flag antibody, and both 
IP and total lysates (Input) were immunoblotted for Flag, B55δ, and 
Derlin 1. c, d Differentiated HepaRG cells were transfected with siNC 
or siPPP2R2D (50 nM) for 6 h, followed by AFB1 treatment (1 μM, 
24  h). Cell lysates were immunoprecipitated with anti-COX-2 anti-
body, and both IP and Input were immunoblotted with B55δ, COX-
2, and Derlin 1 (c). The expression of Derlin 1 (green) and COX-2 
(blue), and co-localization with ER (red) was examined by confocal 
microscopy (left panel). Scale bar 10  μm. Pearson’s correlation for 
the co-localization of COX-2 with Derlin 1 was shown in the bar 
graph (right panel). The overlap sections of COX-2 and Derlin 1 were 
quantified using ImagePro-plus 6.0 (d). GAPDH served as a loading 
control for WB analysis. Representative examples were displayed. All 
data were shown as mean ± SD. *P < 0.05, compared with siNC con-
trol group. #P < 0.05, compared with siNC and AFB1-treated group. 
&P < 0.05, compared with untreated group (colour figure online)
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feedback loop to promote liver inflammatory injury. In the 
present study, DAMPs and IL-1β released from pyroptotic 
hepatocytes activated F4/80 positive KCs (M1 phenotype) to 
secrete pro-inflammatory cytokines in an NLRP3-dependent 
and transcriptional way, forming an immune microenviron-
ment to amplify liver inflammatory injury. Our results are in 
agreement with a report by Wree et al., that overexpression 
of NLRP3 in global and myeloid-specific Nlrp3 knock-in 
mice contributed to pyroptosis of hepatocytes and leuko-
cytes, resulting in severe liver inflammation (Wree et al. 
2014). For transcriptional factors, studies have revealed 
that c-Jun NH2-terminal kinases (JNKs), a major kinase to 
phosphorylate c-Jun, activated by a wide range of stimulus, 
played an important role in obesity-induced liver inflamma-
tion and steatosis, especially in adipose and liver tissue (Pal 
et al. 2016). Active c-Jun, as a component of transcription 
factor AP-1, promoted the expression of pro-inflammatory 
cytokines, such as TNF-α, IL-6, and IL-1β. Moreover, IL-6, 
derived from KCs, influenced phosphorylation of STAT3 
to translocate to the nucleus for pro-inflammatory signal-
ing. Knockout of hepatic STAT3 prevented HSC activation 
and hepatic fibrosis by decreasing the release of fibrogenic 
cytokines (Deng et al. 2013). The activation of STAT3 sign-
aling pathway mediated the pro-inflammatory immune cas-
cades, which promoted the formation of hepatic immune 
microenvironment and liver inflammatory injury. Consistent 
with our data, slight collagen deposition was observed in 
parallel with NLRP3 inflammasome activation in liver tis-
sues. Studies have demonstrated the direct role of NLRP3 
inflammasome to trigger liver inflammation and fibrosis 
through HSC activation in Nlrp3−/− mice (Inzaugarat et al. 
2019; Mridha et al. 2017). In the current study, pro-inflam-
matory signaling of KCs formed a regional immune micro-
environment to aggravate NLRP3 inflammasome activation 
in AFB1-exposed hepatocytes.
Moreover, in hepatocytes, dephosphorylated COX-2Ser601 
promoted mitochondrial translocation of NLRP3, facilitating 
assembly of NLRP3 inflammasome with its adaptor protein 
ASC at the mitochondria, resulting in IL-1β release and 
pyroptosis. In response to pathogens or DAMPs, NLRP3 
inflammasome experiences two steps to induce caspase 
1-dependent pyroptosis: first, transcriptionally encoded 
NLRP3, pro-IL-1β, and pro-IL-18 are released into the 
cytosol via NF-κB pathway; then, they are translocated to 
mitochondria to form a platform of caspase 1 with ASC 
when stimulus, such as disorder of ER reduction-oxidation 
(ER-redox), unfolded protein response (UPR), mitochondrial 
damage, and cathepsin, occurs (Rathinam and Fitzgerald 
2016; Rubartelli 2012). ER-redox homeostasis, determined 
by its signaling mediators endoplasmic reticulum reduc-
tive protein 1α (ERO1α) and protein disulfide isomerase 
(PDI), plays a vital role as the trigger and an effector to 
UPR (Zeeshan et al. 2016). In our study, AFB1 induced 
COX-2 upregulation and NLRP3 inflammasome activation 
via the modulation of ERO1α-dependent ER redox homeo-
stasis mediated by ER response (including ATF4-associated 
ER stress) pathway. There was the ATF4-ERO1α-COX-
2-NLRP3 axis as one of the direct evidences to state that 
AFB1 induced NLRP3 inflammasome-dependent pyroptosis 
via upregulated COX-2 in hepatocytes (unpublished data).
While previous studies suggested that COX-2 or PGs acti-
vated NLRP3 inflammasome via mitochondrial dysfunctions 
in macrophages (Hua et al. 2015; Liu et al. 2018), our data 
reveal that COX-2 interacted with NLRP3 at mitochondria 
and co-regulated NLRP3 inflammasome assembly and acti-
vation. As shown in our previous study, mitochondrial trans-
location of COX-2 promoted the cancer stemness of naso-
pharyngeal carcinoma via recruiting mitochondrial p53 and 
Drp1 for fission (Zhou et al. 2017). Here, we propose that 
dephosphorylated COX-2, which is synthesized and modi-
fied in ER, as a mediator between ER disturbance and mito-
chondrial dysfunction, mediating assembly and activation 
of NLRP3 inflammasome. As for ER-mitochondria cross-
talk of NLRP3, Zhang et al. proposed that increased thiore-
doxin interaction protein (TXNIP), which stimulated by 
reduction-oxidation (redox) disturbance, promoted inflam-
mation and lipid accumulation via activating the NLRP3 
inflammasome in fructose-mediated NASH model (Zhang 
et al. 2015). Bronner et al. revealed that IRE1, a sensor of 
unfolded protein response in ER, mediated cleavage activity 
of caspase 2, which facilitated NLRP3 inflammasome acti-
vation through releasing mitochondrial contents from bone-
marrow-derived macrophages (Bronner et al. 2015). Moreo-
ver, NLRP3 can be recruited on mitochondria-associated 
ER membranes (MAM) (Zhou et al. 2011). We have previ-
ously demonstrated that COX-2 could be located on MAM 
and regulated  Ca2+ transport and mitochondrial-associated 
apoptosis. Whether COX-2 interacts with NLRP3 on MAM 
and co-transfers to mitochondria through MAM remains to 
be further explored.
ER is a focal point of PQC because of the complicated 
folding, modification, and degradation process (Buchberger 
2014). In response to xenobiotics, misfolded or unfolded 
protein is accumulated in the ER lumen. To maintain ER 
homeostasis, ERAD, one of the quality control mechanisms, 
is activated to eliminate accumulated proteins for cellular 
adaption (Sun and Brodsky 2017). Moreover, phospho-
rylation or dephosphorylation, a type of post-translational 
modification, plays an important role in the subcellular dis-
tribution, functional activity, and degradation of proteins 
(Klement and Medzihradszky 2017). Therefore, the mecha-
nism of COX-2 for its phosphorylation and degradation is 
of interest to study. It has been studied that STEL (601–604, 
last 4 amino acid at C-terminal of COX-2), as an inefficient 
ER retention signal of COX-2, tends to transport to Golgi 
for PGs synthesis which slowed down retrograde movement 
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back to ER for degradation (Yuan and Smith 2015). Replace-
ment of STEL with KDEL (a mutation from serine-threonine 
to lysine-aspartate at 601–602), a potent ER retention signal 
of COX-2, like DTEL (a mutation from serine to aspartate at 
601) of our study, could concentrate COX-2 in ER for deg-
radation. In the current study, mimic phosphorylation and 
dephosphorylation of COX-2Ser601 were used to investigate 
the distribution and function of COX-2. For ERAD, Derlin 1 
brought protein from ER to cytosolic through the retro-trans-
location channel, to enhance interaction between caveolin-1 
(CAV-1) and COX-2 relying on its C-terminal for protea-
some degradation (Chen et al. 2013; Mbonye et al. 2008). 
Our results are in agreement with these data that serine 601 
at C-terminal of COX-2 determined its localization and deg-
radation. Furthermore, for the first time, we proposed that 
COX-2 could be dephosphorylated by PP2A-B55δ. Phos-
phorylated COX-2Ser601 has the potential to concentrate in 
ER and interact with Derlin 1 for degradation after B55δ 
intervention, while dephosphorylated COX-2Ser601 by B55δ 
promoted NLRP3 inflammasome activation in hepatocytes.
In summary, our findings point out a novel dephospho-
rylation modification of p-COX-2Ser601 induced by AFB1 
alters the ER localization of COX-2 and ERAD and there-
fore promotes its regulatory function on NLRP3 inflam-
masome activation in hepatocytes. Moreover, IL-1β and 
DAMPs released from pyroptotic hepatocytes stimulate 
STAT3-mediated pro-inflammatory signaling of KCs, to 
form regional immune response cascades which ampli-
fied NLRP3-dependent pyroptosis of hepatocytes and liver 
inflammation. COX-2 could be a potential target molecule 
for prevention and therapy of the inducible NLRP3 inflam-
masome and liver inflammatory injury (Fig. 8).
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